The Need for More Autism Awareness in the Somali American Population

por Bhagia, Jyoti, Kung, Simon
Publicado 2014

Retrospective Analysis of Gabapentin for Alcohol Withdrawal in the Hospital Setting: The Mayo Clinic Experience

por Bates, Ruth E., Leung, Jonathan G., Morgan, Robert J., Fischer, Karen M., Philbrick, Kemuel L., Kung, Simon
Publicado 2020

Impact of sex on antidepressant discontinuation in groups of similar cytochrome P450 phenotypes

por Kosaski, Dylan L, Cole, Kristin C, Wright, Jessica A, El Melik, Razan M, Kung, Simon, Nicholson, Wayne T, Leung, Jonathan G
Publicado 2023

Self‐report screening instruments differentiate bipolar disorder and borderline personality disorder

por Palmer, Brian A., Pahwa, Mehak, Geske, Jennifer R., Kung, Simon, Nassan, Malik, Schak, Kathryn M., Alarcon, Renato D., Frye, Mark A., Singh, Balwinder
Publicado 2021

Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report

por Joseph, Boney, Nunez, Nicolas A., Kung, Simon, Vande Voort, Jennifer L., Pazdernik, Vanessa K., Schak, Kathryn M., Boehm, Stacey M., Carpenter, Brooke, Johnson, Emily K., Malyshev, Grigoriy, Smits, Nathan, Adewunmi, Daniel O., Brown, Sarah K., Singh, Balwinder
Publicado 2023

Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2023, 16, 1164

por Joseph, Boney, Nunez, Nicolas A., Kung, Simon, Vande Voort, Jennifer L., Pazdernik, Vanessa K., Schak, Kathryn M., Boehm, Stacey M., Carpenter, Brooke, Johnson, Emily K., Malyshev, Grigoriy, Smits, Nathan, Adewunmi, Daniel O., Brown, Sarah K., Singh, Balwinder
Publicado 2023

Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection

por Cuéllar-Barboza, Alfredo B., McElroy, Susan L., Veldic, Marin, Singh, Balwinder, Kung, Simon, Romo-Nava, Francisco, Nunez, Nicolas A., Cabello-Arreola, Alejandra, Coombes, Brandon J., Prieto, Miguel, Betcher, Hannah K., Moore, Katherine M., Winham, Stacey J., Biernacka, Joanna M., Frye, Mark A.
Publicado 2020

Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder

por Markota, Matej, Coombes, Brandon J., Larrabee, Beth R., McElroy, Susan L., Bond, David J., Veldic, Marin, Colby, Colin L., Chauhan, Mohit, Cuellar-Barboza, Alfredo B., Fuentes, Manuel, Kung, Simon, Prieto, Miguel L., Rummans, Teresa A., Bobo, William V., Frye, Mark A., Biernacka, Joanna M.
Publicado 2018

Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications

por Veldic, Marin, Ahmed, Ahmed T., Blacker, Caren J., Geske, Jennifer R., Biernacka, Joanna M., Borreggine, Kristin L., Moore, Katherine M., Prieto, Miguel L., Vande Voort, Jennifer L., Croarkin, Paul E., Hoberg, Astrid A., Kung, Simon, Alarcon, Renato D., Keeth, Nicola, Singh, Balwinder, Bobo, William V., Frye, Mark A.
Publicado 2019

Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses

por Frye, Mark A, McElroy, Susan L, Fuentes, Manuel, Sutor, Bruce, Schak, Kathryn M, Galardy, Christine W, Palmer, Brian A, Prieto, Miguel L, Kung, Simon, Sola, Christopher L, Ryu, Euijung, Veldic, Marin, Geske, Jennifer, Cuellar-Barboza, Alfredo, Seymour, Lisa R, Mori, Nicole, Crowe, Scott, Rummans, Teresa A, Biernacka, Joanna M
Publicado 2015